These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28977162)

  • 1. Serum ghrelin levels in papillary thyroid carcinoma.
    Ucan B; Sahin M; Kizilgul M; Ozbek M; Ozdemir S; Calıskan M; Cakal E
    Arch Endocrinol Metab; 2017; 61(5):464-469. PubMed ID: 28977162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
    Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
    Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 5. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
    Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
    Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
    Gao Y; Qu N; Zhang L; Chen JY; Ji QH
    Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
    Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
    Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
    Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
    Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma.
    Zhang Y; Pan J; Xu D; Yang Z; Sun J; Sun L; Wu Y; Qiao H
    Oncol Rep; 2018 Dec; 40(6):3611-3624. PubMed ID: 30542708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
    Lin SY; Wang YY; Sheu WH
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer.
    Kwon H; Park SE; Yun JS; Park CY
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):396-406. PubMed ID: 32615724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
    Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer.
    Gong W; Yang S; Yang X; Guo F
    Clinics (Sao Paulo); 2016 Jul; 71(6):311-4. PubMed ID: 27438563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-451 as a prognostic marker for diagnosis and lymph node metastasis of papillary thyroid carcinoma.
    Zhang M; Wu W; Gao M; Fei Z
    Cancer Biomark; 2017 Jul; 19(4):437-445. PubMed ID: 28582849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIRCULATING THYROID-STIMULATING HORMONE RECEPTOR MESSENGER RNA AS A MARKER OF TUMOR AGGRESSIVENESS IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA.
    Aliyev A; Gupta M; Nasr C; Hatipoglu B; Milas M; Siperstein A; Berber E
    Endocr Pract; 2015 Jul; 21(7):777-81. PubMed ID: 25786552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid microcarcinomas that metastasize to lymph nodes.
    Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B
    Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of lateral neck dissection for papillary thyroid microcarcinomas.
    Lee JH; Chun YS; Chung YS
    Head Neck; 2019 May; 41(5):1367-1371. PubMed ID: 30536753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor border pattern and size help predict lymph node status in papillary microcarcinoma: A clinicopathologic study.
    Taşkın OÇ; Armutlu A; Ağcaoğlu O; Peker Ö; Terzioğlu T; Demirkol MO; Tezelman S; Kapran Y
    Ann Diagn Pathol; 2020 Oct; 48():151592. PubMed ID: 32871504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
    Hou X; Jiang L; Chen C; Zhu X; Ge M
    Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category?
    Xu B; Farhat N; Barletta JA; Hung YP; Biase D; Casadei GP; Onenerk AM; Tuttle RM; Roman BR; Katabi N; Nosé V; Sadow P; Tallini G; Faquin WC; Ghossein R
    Endocrine; 2018 Jan; 59(1):143-150. PubMed ID: 29204912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.